It has been about 2 decades since such effective new therapeutics have been developed for this high-risk population, according to Manali Kamdar, associate professor of medicine/hematology at University of Colorado School of Medicine and clinical director of lymphoma services at CU Cancer Center.
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045